Manage subscriptions   |   FAQ   |   Report Bugs/Errors/Omissions to ors@sfu.ca
3 entries found

Canadian Glycomics Network (GlycoNet)

Sorry, no opportunities were found, please adjust your filters or try another search

20220701
50000

Canadian Glycomics Network (GlycoNet) - Clinical Partnerships 2022–2023 International Verified Date 6 6 days until deadline

Deadline: July 01, 2022
Maximum Award: $50,000 CAD

In this Request for Proposals, the Canadian Glycomics Network (GlycoNet) is seeking to fund Clinical Partnership projects that would offer clinicians and biomedical researchers opportunities to partner with Network Investigators to study glycans or glycosylation changes in disease. This partnership would increase clinician awareness of the role of glycomics in disease, and expand glycomics translational research and its application in more problems of clinical importance. Partnership outcomes could be better understanding of disease, drug development strategies, or new drug targets.

20220915
150000

Canadian Glycomics Network (GlycoNet) - Translational Funding – 2022-2023 Canadian Verified Date 82 82 days until deadline

Deadline: September 15, 2022
Maximum Award: $150,000 CAD

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. These grants further advance/translate projects with proof of concept and protected IP.

20220915
150000

Canadian Glycomics Network (GlycoNet) - Strategic Initiatives 2022–2023 International Verified Date 82 82 days until deadline

Deadline: September 15, 2022
Maximum Award: $150,000 CAD

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer.


x